نتایج جستجو برای: hbsag epitopes mutations

تعداد نتایج: 201746  

Journal: :Journal of clinical microbiology 2015
Zhi-Tao Yang Su-Yuan Huang Li Chen Feng Liu Xiao-Hui Cai Yang-Fan Guo Ming-Jie Wang Yue Han De-Min Yu Jie-Hong Jiang Dong-Hua Zhang Qi-Ming Gong Guo-Qing Zhang Guo-Qing Zang Zhong-Hua Lu Li-Hua Huang Xin-Xin Zhang

Hepatitis B virus (HBV) infection results in different clinical presentation due to different levels of immune response. Our study aimed to characterize HBV full-length genome quasispecies (QS) in patients with different phases of infection to better understand its pathogenesis. Forty treatment-naive HBV-infected patients were enrolled, including 10 cases of acute hepatitis B (AHB), 9 cases of ...

Journal: :Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2009
Pisit Tangkijvanich Piyawat Komolmit Varocha Mahachai Pattaratida Sa-nguanmoo Apiradee Theamboonlers Yong Poovorawan

BACKGROUND Viral genomic mutations have become increasingly recognized as being associated with the outcome of chronic HBV infection. However, the role of viral mutations as a predictor of response to pegylated-interferon (PEG-IFN) therapy has so far remained unclear. STUDY DESIGN Viral mutations in the enhancer II/basal core promoter (BCP)/precore and the pre-S regions were characterized by ...

Journal: :Journal of virology 2009
Mariacarmela Solmone Donatella Vincenti Mattia Carlo Felice Prosperi Alessandro Bruselles Giuseppe Ippolito Maria Rosaria Capobianchi

Direct population sequencing and reverse hybridization (line probe assay [LiPA])-based methods are the most common methods for detecting hepatitis B virus (HBV) drug resistance mutations, although only mutations present in viral quasispecies with a prevalence of > or =20% can be detected by sequencing, and only known mutations are detected by LiPA. Massively parallel ultradeep pyrosequencing (U...

Journal: :Journal of hepatology 2012
Sajad Shahmoradi Yousef Yahyapour Mahmood Mahmoodi Seyed Moayed Alavian Zeinab Fazeli Seyed Mohammad Jazayeri

BACKGROUND & AIMS Occult hepatitis B virus (HBV) infection is a well-recognized clinical entity characterized by the detection of HBV DNA in serum and/or liver in the absence of detectable hepatitis B surface antigen (HBsAg). The frequency of the diagnosis depends on the relative sensitivity of both HBsAg and HBV DNA assays. We aimed at determining the prevalence of occult HBV infection in a hi...

Journal: :Current issues in molecular biology 2014
Shuaibu A Hudu Yasmin A Malik Mohd T Niazlin Nabil S Harmal Zamberi Sekawi

Hepatitis B virus infection is a serious health problem worldwide, and more than 350 million people are chronic carriers, constituting a major global threat. Southeast Asia and the Western Pacific have the highest levels of endemicity in the world, with an estimated seroprevalence ranging between 2% and 31%. Mutations in the hepatitis B surface antigen (HBsAg) have been reported in many parts o...

پایان نامه :وزارت بهداشت، درمان و آموزش پزشکی - دانشگاه علوم پزشکی و خدمات بهداشتی درمانی استان سیستان و بلوچستان 1377

به منظور بررسی نشانگر هپاتیت b در خانواده ناقلین مزمن هپاتیت b در شهرستان زاهدان تعداد 835 نفر اعضای خانواده 226 ناقل مزمن hbsag در مرکز کنترل و درمان هپاتیت مورد مطالعه قرار گرفتند که حدود 14/9 درصد از نظر نشانگر hbsag مثبت بودند و فراوانی مثبت شدن hbsag در مردان 20 درصد به مراتب بیشتر از زنان 11/3 بود. بیشترین فراوانی hbsag بود. بیشترین فراوانی hbsag بترتیب مربوط به پدران 47/1 درصد و برادران ...

Journal: :Karbala international journal of modern science 2023

The spike (S) protein is a major antigenicity site that targets neutralizing antibodies and drugs. growing number of S mutations has become severe problem for developing effective vaccines. Here, we investigated four acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants were the most infectious widespread during COVID-19 pandemic to determine trends patterns mutation-induced changes in...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007
Patrick Miailhes Mary-Anne Trabaud Pierre Pradat Bertrand Lebouché Michèle Chevallier Philippe Chevallier Fabien Zoulim Christian Trepo

BACKGROUND Coinfection with hepatitis B virus (HBV) in human immunodeficiency virus (HIV)-infected patients is common. However, little is known about the natural history of chronic hepatitis B in HIV-infected populations, especially the impact of highly active antiretroviral therapy (HAART) on the outcome of HBV early antigen (HBeAg) and HBV surface antigen (HBsAg) status. METHODS The charact...

Journal: :Journal of immunology 2012
Shao Chong Zhang Eric Martin Mariko Shimada Sasha Blue Godfrey Jennifer Fricke Shirley Locastro Nicole Y Lai Paul Liebesny Jonathan M Carlson Chanson J Brumme Oluwatobi Awele Ogbechie Huabiao Chen Bruce D Walker Zabrina L Brumme Daniel G Kavanagh Sylvie Le Gall

Viruses evade immune detection partly through immune-associated mutations. Analyses of HIV sequences derived from infected individuals have identified numerous examples of HLA-associated mutations within or adjacent to T cell epitopes, but the potential impact of most mutations on epitope production and presentation remains unclear. The multistep breakdown of proteins into epitopes includes tri...

Journal: :Memorias do Instituto Oswaldo Cruz 2006
Michel V F Sucupira Francisco C A Mello Eneida A Santos Christian Niel Valeria C Rolla Juçara Arabe Selma A Gomes

Hepatitis B virus (HBV) molecular profiles were determined for 44 patients who were infected with human immunodeficiency virus (HIV) type 1 and had antibodies to the hepatitis B core antigen (anti-HBc), with and without other HBV serological markers. In this population, 70% of the patients were under lamivudine treatment as a component of antiretroviral therapy. HBV DNA was detected in 14 (32%)...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید